安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
Mcl1-IN-8 (Compound 8) 是一种具有口服活性的 Mcl-1-PUMA 界面抑制剂,Ki 为 0.3 μM. Mcl1-IN-8 在减少 PUMA 依赖性细胞凋亡方面表现出双重活性,同时在癌细胞中失活 Mcl-1 介导的抗细胞凋亡。
Mcl1-IN-8 (Comp8) is a Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. Mcl1-IN-8 (Comp8) exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells[1].
[1]. Liu J, et al. Targeting the apoptotic Mcl-1-PUMA interface with a dual-acting compound. Oncotarget. 2017 Apr 20;8(33):54236-54242.
动态评分
0.0